The use of additive technologies to increase adherence to treatment, increase the efficiency of chemotherapy and correction of indicators of anxiety and depression among patients with destructive pulmonary tuberculosis

Cover Page

Cite item

Full Text

Abstract

Background. Currently, there is no «golden standard» in terms of correction of adherence to treatment of patients with tuberculosis and its adequate assessment. This paper presents the experience of applying the 3D lung reconstruction method, which was used among patients with tuberculosis to modify their level of adherence, as well as to increase the effectiveness of treatment and change the indicators of anxiety and depression.

Aims. To give a brief description of the level of adherence to treatment and the overall effectiveness of chemotherapy in newly diagnosed patients with tuberculosis according to the data of the department for patients with respiratory tuberculosis of the Nizhny Novgorod Regional Clinical Tuberculosis Dispensary. To increase the level of adherence to treatment and increase the effectiveness of chemotherapy in newly diagnosed patients with destructive forms of pulmonary tuberculosis using additive technologies using the method of three-dimensional reconstruction of lung tissue. To assess and correct the dynamics of manifestations of symptoms of anxiety and depression among newly diagnosed patients with destructive forms of pulmonary tuberculosis using additive technologies using the method of three-dimensional reconstruction of lung tissue.

Materials and methods. The present work is based on a retrospective-prospective analysis of the results of treatment of newly diagnosed patients with destructive forms of pulmonary tuberculosis (167 people), who were observed in the Nizhny Novgorod Regional Clinical Tuberculosis Dispensary. The patients included in the study were divided into two groups. For patients of the 1st group, lung models were made, among them a questionnaire was conducted using the MMAS-4 questionnaire and the HADS scale. For patients of the 2nd group, lung models were not made, and no survey was conducted.

Results. According to the results of the study in the department for patients with respiratory tuberculosis of the Nizhny Novgorod Regional Clinical Tuberculosis Dispensary (observation period from 2016 to 2020), a negative trend was found in an increase in the number of unauthorized departures from the structural unit and violations of the regimen among patients. A course of polychemotherapy was recognized as effective in the 1st group (in terms of bacterial excretion) in 93.0% of patients (64/69), and in the 2nd group (the same indicator) – in 67.3% (66/98); χ2=16.940, df=1; p<0.001. The largest number of abacilated patients was observed in the 1st group. In the case of showing patients three-dimensional anatomical tactile models of the lungs, the probability of closing decay cavities increased by 32.2% (γ-test=-0.322; p=0.034). The absence of the demonstration of personalized three-dimensional anatomical tactile models of the lungs contributed to an increase in the occurrence of disadvantage in the outcome of therapy by 77.2% (γ-test=-0.772; p<0.001). The chance of achieving an effective course of chemotherapy was 4.2 times higher among patients of the 1st group (odds ratio 4.267, 95% confidence interval 1.523–11.953). In the absence of data on the patient’s interaction with the tactile pulmonary model, the risk of noncompliance increased by 47.6% (γ-test=-0.476; p=0.020). After the use of three-dimensional anatomical tactile models of the lungs among patients of the 1st group, their level of adherence to treatment increased (according to the MMAS-4 questionnaire) with a result of 4 points [4; 4] – maximum score of the MMAS-4 questionnaire – (W=2278, Z=-7.267; p<0.001) and the psychological load significantly decreased (according to the HADS scale) with a score of 7 points [5; 10] – «no significant symptoms of anxiety and depression» (W=2405, Z=-7.165; p<0.001).

Conclusion. The use of additive technologies in the anti-tuberculosis organization has made it possible to improve the profile of adherence of tuberculosis patients to polychemotherapy, increase the effectiveness of treatment, and correct indicators of anxiety and depression among newly diagnosed patients with destructive pulmonary tuberculosis.

About the authors

Alexey G. Naumov

Privolzhsky Research Medical University; Nizhny Novgorod Regional Clinical Tuberculosis Dispensary

Author for correspondence.
Email: naumov_a@pimunn.net
ORCID iD: 0000-0003-0412-6877

Аssistant

Russian Federation, Nizhny Novgorod; Nizhny Novgorod

Alexander S. Shprykov

Privolzhsky Research Medical University

Email: shprykov_a@pimunn.net
ORCID iD: 0000-0002-2780-6704

D. Sci. (Med.), Prof.

Russian Federation, Nizhny Novgorod

Marina A. Dolgova

Nizhny Novgorod Regional Clinical Tuberculosis Dispensary

Email: dolgova.marina65@yandex.ru
ORCID iD: 0000-0002-8046-3114

Deputy Chief doctor

Russian Federation, Nizhny Novgorod

Natalia V. Fomina

Privolzhsky Research Medical University; Minin Nizhny Novgorod State Pedagogical University

Email: fominataly@yandex.ru
ORCID iD: 0000-0003-0290-7549

Cand. Sci. (Psychol.), Assoc. Prof.

Russian Federation, Nizhny Novgorod; Nizhny Novgorod

References

  1. Васильева И.А., Тестов В.В., Стерликов С.А. Эпидемическая ситуация по туберкулезу в годы пандемии COVID-19 – 2020–2021 гг. Туберкулез и болезни легких. 2022;100(3):6-12 [Vasilyeva IA, Testov VV, Sterlikov SА. Tuberculosis situation in the years of the COVID-19 pandemic – 2020–2021. Tuberculosis and Lung Diseases. 2022;100(3):6-12 (in Russian)]. doi: 10.21292/2075-1230-2022-100-3-6-12
  2. Нечаева О.Б. Эпидемическая ситуация по туберкулезу в России. Туберкулез и болезни легких. 2018;96(8):15-24 [Nechaeva OB. Tb situation in Russia. Tuberculosis and Lung Diseases. 2018;96(8):15-24 (in Russian)]. doi: 10.21292/2075-1230-2018-96-8-15-24
  3. Цыбикова Э.Б., Пунга В.В., Русакова Л.И. Туберкулез, сочетанный с ВИЧ-инфекцией, в России: статистика и взаимосвязи. Туберкулез и болезни легких. 2018;96(12):9-17 [Tsybikova EB, Punga VV, Rusakova LI. Tuberculosis with concurrent HIV infection in Russia: Statistics and correlations. Tuberculosis and Lung Diseases. 2018;96(12):9-17 (in Russian)]. doi: 10.21292/2075-1230-2018-96-12-9-17
  4. Афанасьев Е.И., Русских О.Е. Современные тенденции в эпидемиологии туберкулеза и ВИЧ-инфекции в мире и в Российской Федерации. РМЖ. 2021;3:24-6 [Afanasiev EI, Russkikh OE. Modern trends in the epidemiology of tuberculosis and HIV infection worldwide and in the Russian Federation. RMJ. 2021;3:24-6 (in Russian)].
  5. Letang E, Ellis J, Naidoo K, et al. Tuberculosis-HIV co-infection: Progress and challenges after two decades of global antiretroviral treatment roll-out. Arch Bronconeumol. 2020;56(7):446-54. doi: 10.1016/j.arbr.2019.11.013
  6. Bruchfeld J, Correia-Neves M, Källenius G. Tuberculosis and HIV Coinfection. Cold Spring Harb Perspect Med. 2015;5(7):a017871. doi: 10.1101/cshperspect.a017871
  7. Стерликов С.А., Нечаева О.Б., Галкин В.Б., и др. Отраслевые и экономические показатели противотуберкулезной работы в 2018–2019 гг. Аналитический обзор основных показателей и статистические материалы. М.: РИО ЦНИИОИЗ, 2020 [Sterlikov SA, Nechaeva OB, Galkin VB, et al. Otraslevye i ekonomicheskie pokazateli protivotuberkuleznoi raboty v 2018–2019 gg. Analiticheskii obzor osnovnykh pokazatelei i statisticheskie materialy. Moscow: RIO TsNIIOIZ, 2020 (in Russian)].
  8. Chakaya J, Khan M, Ntoumi F, et al. Global tuberculosis report 2020 – reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021;113 Suppl. 1(Suppl. 1):S7-12. doi: 10.1016/j.ijid.2021.02.107
  9. Васильева И.А., Белиловский Е.М., Борисов С.Е., Стерликов С.А. Туберкулез с множественной лекарственной устойчивостью возбудителя в странах мира и в Российской Федерации. Туберкулез и болезни легких. 2017;95(11):5-17 [Vаsilyevа IА, Belilovsky EM, Borisov SE, Sterlikov SА. Multi drug resistant tuberculosos in the countries of the outer world and in the Russian Federation. Tuberculosis and Lung Diseases. 2017;95(11):5-17 (in Russian)]. doi: 10.21292/2075-1230-2017-95-11-5-17
  10. Панова Л.В., Овсянкина Е.С., Ловачева О.В., и др. Персонифицированное лечение туберкулеза легких с МЛУ/ШЛУ МБТ у подростков. Туберкулез и болезни легких. 2018;96(2):55-63 [Pаnovа LV, Ovsyankinа ES, Lovаchevа OV, et al. Individual treatment of pulmonary MDR/XDR tuberculosis in adolescents. Tuberculosis and Lung Diseases. 2018;96(2):55-63 (in Russian)]. doi: 10.21292/2075-1230-2018-96-2-55-63
  11. Белостоцкий А.В., Касаева Т.Ч., Кузьмина Н.В., Нелидова Н.В. Проблема приверженности больных туберкулезом к лечению. Туберкулез и болезни легких. 2015;4:4-9 [Belostotsky AV, Kasaeva TCh, Kuzmina NV, Nelidov NV. Problem of treatment adherence in tuberculosis patients. Tuberculosis and Lung Diseases. 2015;(4):4-9 (in Russian)].
  12. Jang JG, Chung JH. Diagnosis and treatment of multidrug-resistant tuberculosis. Yeungnam Univ J Med. 2020;37(4):277-85. doi: 10.12701/yujm.2020.00626
  13. Гельцер Б.И., Шахгельдян К.И., Кривелевич Е.Б., и др. Некоторые подходы к оценке эффективности региональной фтизиатрической службы. Туберкулез и болезни легких. 2017;95(12):28-34 [Geltser BI, Shаkhgeldyan KI, Krivelevich EV, et al. Certain approaches to efficiency evaluation of the regional tb services. Tuberculosis and Lung Diseases. 2017;95(12):28-34 (in Russian)]. doi: 10.21292/2075-1230-2017-95-12-28-34
  14. Пьянзова Т.В. Вопросы взаимоотношений в диаде врач – пациент. Туберкулез и болезни легких. 2014;1:3-8 [Pyanzova TV. Problems in the physician–patient dyad. Tuberculosis and Lung Diseases. 2014;1:3-8 (in Russian)].
  15. Paul S, Akter R, Aftab A, et al. Knowledge and attitude of key community members towards tuberculosis: Mixed method study from BRAC TB control areas in Bangladesh. BMC Public Health. 2015;15:52. doi: 10.1186/s12889-015-1390-5
  16. Лепшина С.М., Ряполова Т.Л., Лепшина Е.А., Атаев О.В. Мультирезистентный туберкулез: проблема стигматизации, самостигматизации, дискриминации больных. Вестник гигиены и эпидемиологии. 2020;24(4):457-9 [Lepshina SM, Ryapolova TL, Lepshina EA, Ataev OV. Multi-resistant tuberculosis: The problem of stigmatization, self-stigmatization, discrimination of patients. Vestnik of Hygiene and Epidemiology. 2020;24(4):457-9 (in Russian)].
  17. Kibrisli E, Bez Y, Yilmaz A, et al. High social anxiety and poor quality of life in patients with pulmonary tuberculosis. Medicine (Baltimore). 2015;94(3):e413. doi: 10.1097/MD.0000000000000413
  18. Золотова Н.В., Баранова Г.В., Стрельцов В.В., и др. Особенности переносимости противотуберкулезной химиотерапии с учетом психологического статуса пациентов. Туберкулез и болезни легких. 2017;95(4):15-9 [Zolotova NV, Baranova GV, Streltsov VV, et al. Specific features of anti-tuberculosis chemotherapy tolerance in the light of psychological status of patients. Tuberculosis and Lung Diseases. 2017;95(4):15-9 (in Russian)]. doi: 10.21292/2075-1230-2017-95-4-15-19
  19. Золотова Н.В., Баранова Г.В., Стрельцов В.В., и др. Психологические особенности впервые выявленных больных туберкулезом легких в аспекте оказания психотерапевтической помощи в период стационарного лечения. Туберкулез и болезни легких. 2019;97(1):18-24 [Zolotova NV, Baranova GV, Streltsov VV, et al. Specific psychological features of new pulmonary tuberculosis patients in the context of psychotherapeutic care during in-patient treatment. Tuberculosis and Lung Diseases. 2019;97(1):18-24 (in Russian)]. doi: 10.21292/2075-1230-2019-97-1-18-24
  20. Rondags A, Himawan AB, Metsemakers JF, Kristina TN. Factors influencing non-adherence to tuberculosis treatment in Jepara, central Java, Indonesia. Southeast Asian J Trop Med Public Health. 2014;45(4):859-68. PMID: 25427354
  21. Shen TC, Wang CY, Lin CL, et al. People with tuberculosis are associated with a subsequent risk of depression. Eur J Intern Med. 2014;25(10):936-40. doi: 10.1016/j.ejim.2014.10.006
  22. Shiotani R, Hennink M. Socio-cultural influences on adherence to tuberculosis treatment in rural India. Glob Public Health. 2014;9(10):1239-51. doi: 10.1080/17441692.2014.953562
  23. Ломаченков В.Д., Кошелева Г.Я. Психологические особенности мужчин и женщин, впервые заболевших туберкулезом легких, и их социальная адаптация. Проблемы туберкулеза. 1997;74(3):9-11 [Lomachenkov VD, Kosheleva GYa. Psychological characteristics of men and women with pulmonary tuberculosis for the first time, and their social adaptation. Problemy Tuberkuleza. 1997;74(3):9-11 (in Russian)].
  24. Наумов А.Г., Шпрыков А.С., Крюков Э.Р. Опыт использования аддитивных технологий на примере трехмерной реконструкции легких в клинической практике противотуберкулезного диспансера. Пульмонология. 2022;32(1):109-17 [Naumov AG, Shprykov AS, Kryukov ER. The experience of using additive technologies for three-dimensional reconstruction of the lungs in the clinical practice of a tuberculosis dispensary. Pulmonologiya. 2022;32(1):109-17 (in Russian)]. doi: 10.18093/0869-0189-2022-32-1-109-117
  25. Ma L, Zhou Y, Zhu Y, et al. 3D-printed guiding templates for improved osteosarcoma resection. Sci Rep. 2016;6:23335. doi: 10.1038/srep23335
  26. Доценко И.А., Котомцев В.В., Медвинский И.Д., и др. Использование аддитивных технологий в персонифицированной хирургии позвоночника (экспериментальное исследование). РМЖ. Медицинское обозрение. 2020;4(2):83-8 [Dotsenko IA, Kotomtsev VV, Medvinskiy ID, et al. Additive technologies in spinal personalized surgery (experimental study). Russian Medical Review. 2020;4(2):83-8 (in Russian)]. doi: 10.32364/2587-6821-2020-4-2-83-88
  27. Ruiters S, Sun Y, de Jong S, et al. Computer-aided design and three-dimensional printing in the manufacturing of an ocular prosthesis. Br J Ophthalmol. 2016;100(7):879-81. doi: 10.1136/bjophthalmol-2016-308399
  28. Mulberry G, White KA, Vidya M, et al. 3D printing and milling a real-time PCR device for infectious disease diagnostics. PLoS One. 2017;12(6):1-18. doi: 10.1371/journal.pone.0179133
  29. Жданова С.Н., Огарков О.Б., Кошкина О.Г., и др. Опыт использования мобильного приложения для повышения приверженности к лечению больных туберкулезом и ВИЧ-инфекцией. Туберкулез и болезни легких. 2021;99(11):17-24 [Zhdаnovа SN, Ogаrkov OB, Koshkinа OG, et al. Experience of using a mobile app to improve adherence to treatment in patients with TB/HIV coinfection. Tuberculosis and Lung Diseases. 2021;99(11):17-24 (in Russian)]. doi: 10.21292/2075-1230-2021-99-11-17-24
  30. Павлюченкова Н.А., Васильева И.А., Самойлова А.Г., Тюлькова Т.Е. Видеоконтролируемое лечение – инновационный метод мониторинга терапии туберкулеза в условиях ограниченных ресурсов системы здравоохранения. Туберкулез и болезни легких. 2022;100(2):53-60 [Pavlyuchenkova NА, Vasilyeva IА, Samoylova АG, Tyulkova TE. Video observed treatment is an innovative method of tuberculosis treatment observation in resource-limited health care settings. Tuberculosis and Lung Diseases. 2022;100(2):53-60 (in Russian)]. doi: 10.21292/2075-1230-2022-100-2-53-60
  31. Шерстнева Т.В., Скорняков С.Н., Подгаева В.А., и др. Мультидисциплинарный подход в работе по формированию приверженности лечению больных туберкулезом. Туберкулез и болезни легких. 2017;95(1):34-41 [Sherstneva TV, Skornyakov SN, Podgaeva VA, et al. Multidisciplinary approach to supporting treatment compliance in tuberculosis patients. Tuberculosis and Lung Diseases. 2017;95(1):34-41 (in Russian)]. doi: 10.21292/2075-1230-2017-95-1-34-41
  32. Wang N, Shewade HD, Thekkur P, et al. Electronic medication monitor for people with tuberculosis: Implementation experience from thirty countries in China. PloS One. 2020;15(4):e0232337. doi: 10.1371/journal.pone.0232337
  33. Park S, Sentissi I, Gil SJ, et al. Medication event monitoring system for infectious tuberculosis treatment in Morocco: A retrospective cohort study. Int J Environ Res Public Health. 2019;16(3):412. doi: 10.3390/ijerph16030412
  34. Баврина А.П. Основные понятия статистики. Медицинский альманах. 2020;3(64):101-11 [Bavrina A P. Basic concepts of statistics. Medicinskij Al'manah. 2020;3(64):101-11 (in Russian)].
  35. Филиппов А.В., Мельникова И.Н., Косенков С.А., и др. Оценка приверженности больных туберкулезом к лечению: опыт применения градуированной шкалы на стационарном этапе. Туберкулез и социально значимые заболевания. 2019;1:42-9 [Filippov AV, Melnikova IN, Kosenkov SA, et al. Evaluation of the treatment adherence in TB-patients: experience of the graduated scale in the in-patient clinic. Tuberculosis and Socially Significant Diseases. 2019;1:42-9 (in Russian)].
  36. Лукина Ю.В., Марцевич С.Ю., Кутишенко Н.П. Шкала Мориски–Грина: плюсы и минусы универсального теста, работа над ошибками. Рациональная фармакотерапия в кардиологии. 2016;12(1):63-5 [Lukina YuV, Martsevich SYu, Kutishenko NP. The Moriscos–Green scale: The pros and cons of universal test, correction of mistakes. Rational Pharmacotherapy in Cardiology. 2016;12(1):63-5 (in Russian)]. doi: 10.20996/1819-6446-2016-12-1-63-65
  37. Небиеридзе Д.В., Сарычева А.Ф., Камышова Т.В., Сафарян А.С. Актуальные вопросы контроля артериальной гипертензии и нарушения липидного обмена: фокус на приверженность. Профилактическая медицина. 2015;18(6):87-90 [Nebieridze DV, Sarycheva AF, Kamyshova TV, Safarian AS. Topical issues of the control of hypertension and lipid metabolic disturbances: A focus on medication adherence. Russian Journal of Preventive Medicine. 2015;18(6):87-90 (in Russian)]. doi: 10.17116/profmed201518687-90
  38. Пушкарев Г.С., Кузнецов В.А., Ярославская Е.И., Бессонов И.С. Надежность и валидность русскоязычной версии шкалы DS14 у больных ишемической болезнью сердца. Российский кардиологический журнал. 2016;21(6):50-4 [Pushkarev GS, Kuznetsov VA, Yaroslavskaya EI, Bessonov IS. Reliability and validity of Russian version of DS14 Score for ischemic heart disease patients. Russian Journal of Cardiology. 2016;21(6):50-4 (in Russian)]. doi: 10.15829/1560-4071-2016-6-50-54
  39. Шальнова С.А., Евстифеева С.Е., Деев А.Д., и др. Распространенность тревоги и депрессии в различных регионах Российской Федерации и ее ассоциации с социально-демографическими факторами (по данным исследования ЭССЕ-РФ). Терапевтический архив. 2014;86(12):53-60 [Shalnova SA, Evstifeeva SE, Deev AD, et al. The prevalence of anxiety and depression in different regions of the Russian Federation and its association with sociodemographic factors (according to the data of the ESSE-RF study). Terapevticheskii Arkhiv (Ter. Arkh.). 2014;86(12):53-60 (in Russian)]. doi: 10.17116/terarkh2014861253-60
  40. Silberstein JL, Maddox MM, Dorsey P, et al. Physical models of renal malignancies using standard cross-sectional imaging and 3-dimensional printers: A pilot study. Urology. 2014;84(2):268-72. doi: 10.1016/j.urology.2014.03.042
  41. Robles-Martinez P, Xu X, Trenfield SJ, et al. 3D printing of a multi-layered polypill containing six drugs using a novel stereolithographic method. Pharmaceutics. 2019;11(6):274. doi: 10.3390/pharmaceutics11060274

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. The result of studying the belonging of samples to the normal distribution in the form of a Q–Q plot. The parameter is the age of patients in both groups.

Download (118KB)
Indexing metadata

Copyright (c) 2024 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies